Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation

Macarena S. Arrázola,Matías Lira,Felipe Véliz‐Valverde,Gabriel Quiroz,Somya Iqbal,Samantha L. Eaton,Douglas J. Lamont,Hernán Huerta,Gonzalo Ureta,Sebastián Bernales,J. César Cárdenas,Waldo Cerpa,Thomas M. Wishart,Felipe A. Court
DOI: https://doi.org/10.1111/acel.13814
IF: 11.005
2023-03-29
Aging Cell
Abstract:Necroptosis is activated along brain aging, and is associated with the deterioration of axons and synaptic function, increasing neuroinflammation and affecting cognitive processes, such as learning and memory. Remarkably, the inhibition of necroptosis through genetic (MLKL knockout) or pharmacological (RIPK3 inhibition) strategies, reverts age‐associated hippocampal changes, restores synaptic function, and reverses learning and memory to youthful levels. Age is the main risk factor for the development of neurodegenerative diseases. In the aged brain, axonal degeneration is an early pathological event, preceding neuronal dysfunction, and cognitive disabilities in humans, primates, rodents, and invertebrates. Necroptosis mediates degeneration of injured axons, but whether necroptosis triggers neurodegeneration and cognitive impairment along aging is unknown. Here, we show that the loss of the necroptotic effector Mlkl was sufficient to delay age‐associated axonal degeneration and neuroinflammation, protecting against decreased synaptic transmission and memory decline in aged mice. Moreover, short‐term pharmacologic inhibition of necroptosis targeting RIPK3 in aged mice, reverted structural and functional hippocampal impairment, both at the electrophysiological and behavioral level. Finally, a quantitative proteomic analysis revealed that necroptosis inhibition leads to an overall improvement of the aged hippocampal proteome, including a subclass of molecular biofunctions associated with brain rejuvenation, such as long‐term potentiation and synaptic plasticity. Our results demonstrate that necroptosis contributes to age‐dependent brain degeneration, disturbing hippocampal neuronal connectivity, and cognitive function. Therefore, necroptosis inhibition constitutes a potential geroprotective strategy to treat age‐related disabilities associated with memory impairment and cognitive decline.
cell biology,geriatrics & gerontology
What problem does this paper attempt to address?